Cargando…
CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation
BACKGROUND: β-Thalassemias represent a group of genetic disorders caused by human hemoglobin beta (HBB) gene mutations. The radical curative approach is to correct the mutations causing the disease. CRISPR-CAS9 is a novel gene-editing technology that can be used auspiciously for the treatment of the...
Autores principales: | Gabr, Hala, El Ghamrawy, Mona Kamal, Almaeen, Abdulrahman H., Abdelhafiz, Ahmed Samir, Hassan, Aya Osama Saad, El Sissy, Maha Hamdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488347/ https://www.ncbi.nlm.nih.gov/pubmed/32912325 http://dx.doi.org/10.1186/s13287-020-01876-4 |
Ejemplares similares
-
5588571 DYSLIPIDEMIA IN TRANSFUSION-DEPENDENT-THALASSEMIA PATIENTS AND ITS CORRELATION WITH SERUM VITAMIN D LEVEL
por: El-Ghamrawy, M., et al.
Publicado: (2023) -
Adenine base editor–mediated correction of the common and severe IVS1-110 (G>A) β-thalassemia mutation
por: Hardouin, Giulia, et al.
Publicado: (2023) -
PB2522: LIPID PROFILE AND CARDIAC FUNCTIONS IN EGYPTIAN SICKLE CELL DISEASE PATIENTS: A SINGLE CENTER STUDY
por: El Ghamrawy, Mona, et al.
Publicado: (2023) -
Prevalence of Hepatitis C among Egyptian Children with Sickle Cell Disease and the Role of IL28b Gene Polymorphisms in Spontaneous Viral Clearance
por: Mousa, Somaia Mohammed, et al.
Publicado: (2016) -
Risk Factors Associated with Needlestick Injuries among Health Care Workers in Menoufia Governorate, Egypt
por: Marawan Gabr, Hala, et al.
Publicado: (2018)